Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients

J Allergy Clin Immunol. 2013 Mar;131(3):909-11. doi: 10.1016/j.jaci.2012.08.036. Epub 2012 Oct 11.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Angioedemas, Hereditary / drug therapy*
  • Antibodies / blood
  • Child
  • Complement C1 Inhibitor Protein / administration & dosage*
  • Complement C1 Inhibitor Protein / immunology
  • Female
  • Humans
  • Male
  • Recombinant Proteins / administration & dosage
  • Treatment Outcome

Substances

  • Antibodies
  • Complement C1 Inhibitor Protein
  • Recombinant Proteins